Antonio Macrì Selected Research

Antonio Macrì Research Topics

Disease

16	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2009
15	Neoplasms (Cancer) 02/2023 - 07/2011
7	Stomach Neoplasms (Stomach Cancer) 09/2022 - 03/2009
7	Carcinoma (Carcinomatosis) 03/2021 - 02/2010
4	Peritoneal Neoplasms 11/2022 - 02/2016
4	Pancreatitis 05/2011 - 04/2003
3	Colitis 01/2022 - 01/2016
3	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 04/2017
2	Peritoneal Diseases 12/2021 - 12/2019
2	Breast Neoplasms (Breast Cancer) 12/2014 - 01/2009
2	Ovarian Epithelial Carcinoma 08/2011 - 01/2011
1	Carcinogenesis 03/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019
1	Splenomegaly 01/2019
1	Pathologic Complete Response 04/2017
1	Weight Loss (Weight Reduction) 10/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2016
1	Water Intoxication 02/2016
1	Tremor (Tremors) 01/2015
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2015
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 01/2015
1	Confusion (Bewilderment) 01/2015
1	Ataxia (Dyssynergia) 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Cholelithiasis 12/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2014
1	Paraganglioma (Paragangliomas) 12/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2014
1	Ascites 10/2014
1	Pleural Effusion (Pleural Effusions) 07/2014
1	Myocardial Infarction 07/2014
1	Shock 05/2011
1	Adenocarcinoma 03/2009
1	Leiomyosarcoma 01/2009
1	Epithelioid Leiomyoma 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Leiomyoma (Uterine Fibroids) 01/2009
1	Gallstones (Gallstone) 10/2005
1	Pathologic Constriction (Stenosis) 10/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2005

Drug/Important Bio-Agent (IBA)

4	CeruletideIBA 05/2011 - 04/2003
3	AerosolsIBA 02/2023 - 10/2019
3	Ethanol (Ethyl Alcohol)IBA 06/2021 - 01/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 01/2016
2	PolydeoxyribonucleotidesIBA 01/2022 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2009
2	2,4-dinitrofluorobenzene sulfonic acidIBA 10/2016 - 01/2016
2	dinitrobenzenesulfonic acidIBA 10/2016 - 01/2016
2	Peptides (Polypeptides)IBA 12/2014 - 05/2011
2	NF-kappa B (NF-kB)IBA 12/2003 - 04/2003
1	OMS 2017IBA 06/2021
1	beta CateninIBA 03/2021
1	CateninsIBA 03/2021
1	Aquaporin 1IBA 03/2021
1	Aquaporins (Water Channels)IBA 03/2021
1	N-(4-isothiocyanatophenethyl)spiperoneIBA 10/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	SodiumIBA 10/2016
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 10/2016
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2016
1	zileuton (Zyflo)FDA Link 10/2016
1	Drinking WaterIBA 10/2016
1	Cyclooxygenase 1IBA 10/2016
1	flavocoxidIBA 10/2016
1	Celecoxib (Celebrex)FDA Link 10/2016
1	AlbuminsIBA 02/2016
1	Thiamine (Aneurin)FDA Link 01/2015
1	CatecholaminesIBA 12/2014
1	MucinsIBA 07/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2011
1	Chlorisondamine (Chlorisondamine Chloride)IBA 05/2011
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 05/2011
1	butir-His-Phe-Arg-Trp-Sar-NH2IBA 05/2011
1	MelanocortinsIBA 05/2011
1	Imatinib Mesylate (Gleevec)FDA Link 03/2009
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 01/2009
1	OsteopontinIBA 01/2009
1	Prednisone (Sone)FDA LinkGeneric 04/2005

Therapy/Procedure

23	Hyperthermic Intraperitoneal Chemotherapy 01/2024 - 02/2010
18	Cytoreduction Surgical Procedures 01/2024 - 02/2010
9	Drug Therapy (Chemotherapy) 01/2024 - 03/2009
5	Therapeutics 09/2022 - 01/2009
3	Neoadjuvant Therapy 02/2021 - 04/2017
2	Combined Modality Therapy 01/2024 - 09/2022
2	Cholecystectomy 12/2014 - 10/2005
2	Injections 05/2011 - 10/2004
1	Gastrectomy 12/2021
1	Radiofrequency Ablation 06/2021
1	Tattooing 06/2021
1	Blood Transfusion (Blood Transfusions) 03/2021
1	Splenectomy 01/2019
1	Radiotherapy 01/2015
1	Palliative Care (Palliative Therapy) 12/2014
1	Nephrectomy 10/2014
1	Operative Time 10/2014
1	Intraperitoneal Injections 05/2011
1	Vagotomy 05/2011
1	Sphincterotomy 10/2005
1	Gastroenterostomy 10/2005